Paige Secures Funding from Goldman Sachs to Continue Innovation in Digital Pathology

 Paige Secures Funding from Goldman Sachs to Continue Innovation in Digital Pathology

Paige Secures Funding from Goldman Sachs to Continue Innovation in Digital Pathology

Shots:

  • Paige has completed a $70M series B funding round that included $15M in additional investment from Goldman Sachs Merchant Banking Division. The firm has so far invested $20M in Paige
  • Additionally, Healthcare Venture has also invested $5M bringing Paige’s total capital raised to over $95M.  Paige will utilize its funding to ramp up its position in transforming pathology workflows while working with pharmaceutical firms to create custom diagnostic and clinical trial solutions
  • Paige’s platform delivers technology to pathologists to increase diagnostic confidence and productivity. The tool offers an intuitive user experience, minimize IT burden and costs while ensuring patient safety and data privacy

Click here to read full press release/ article | Ref: Paige | Image: Twitter

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post